Загрузка...
Ceftobiprole Perspective: Current and Potential Future Indications
Ceftobiprole combines an excellent spectrum for community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) pathogens, with a low/medium MDR risk, and the β-lactams’ safety in frail patients admitted to the hospital in internal medicine wards which may be at high risk of adverse events...
Сохранить в:
| Опубликовано в: : | Antibiotics (Basel) |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915564/ https://ncbi.nlm.nih.gov/pubmed/33567771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10020170 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|